In the second installment of our four-part series, "Trading Traditional Topicals for Targeted Therapies: Improving Disease Management for AD," we're tackling a topic that's often misunderstood and highly challenging: Topical Steroid Withdrawal (TSW). Supported by an educational grant from Arcutis, this episode, "Topical Steroid Withdrawal – Myths vs Science," features expert dermatologists Dr Mona Shahriari, MD, and Dr Peter Lio, MD.
Join us as we separate fact from fiction and dive deep into:
-
The common pitfalls of overusing or misusing topical corticosteroids (TCS)
-
How to recognize the telltale signs and symptoms of TSW
-
Effective and compassionate strategies for managing TSW
-
The key to using TCS responsibly
-
Understanding when to pivot to targeted, non-steroidal treatments.
For those interested in the science behind TSW, we've included a link to a recent publication on the disease mechanism: Topical Steroid Withdrawal Is a Targetable Excess of Mitochondrial NAD - PubMed